Which has grown faster, AUPH or BCRX?

Over the past five years, BCRX grew revenue faster — AUPH at a 40.17% CAGR versus BCRX at 64.07%.

Is AUPH or BCRX more profitable?

AUPH runs the higher net margin — AUPH at 100.84% versus BCRX at -40.90%.

How have AUPH and BCRX total returns compared?

Over the past 10 years, AUPH delivered 14.53% and BCRX delivered 5.82% annualized total return. Past performance doesn't predict future results.

Aurinia Pharmaceuticals Inc. (AUPH) vs BioCryst Pharmaceuticals, Inc. (BCRX)

A side-by-side comparison of Aurinia Pharmaceuticals Inc. and BioCryst Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AUPH

Aurinia Pharmaceuticals Inc.

$2.02B

$15.72HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

BCRX

BioCryst Pharmaceuticals, Inc.

$2.06B

$8.10HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — AUPH vs BCRX

growth of $100 · dividends reinvested · last 10y

AUPH +288.1% (+14.5%/yr)BCRX +78.8% (+6.0%/yr)AUPH compounded faster over this window

AUPH BCRX

AUPH vs BCRX: by the numbers

•BCRX is the larger company ($2.06B vs $2.02B market cap).
•AUPH is profitable (100.84% net margin) while BCRX runs a net loss (-40.90%).
•BCRX grew revenue faster over the past five years (64.07% vs 40.17% CAGR).

Metrics side by side

Valuation

Metric	AUPH	BCRX
P/E ratio	6.86	N/A
Forward P/E	16.65	N/A
P/S ratio	6.49	2.19
P/B ratio	3.29	N/A
EV / EBITDA	11.18	N/A
FCF yield	8.59%	17.35%

Profitability

Metric	AUPH	BCRX
Gross margin	90.36%	97.82%
Operating margin	37.06%	38.98%
Net margin	100.84%	-40.90%
ROE	51.09%	N/A
ROIC	21.77%	-89.73%

Growth (annualized)

Metric	AUPH	BCRX
Revenue CAGR (5Y)	40.17%	64.07%
Total return CAGR (5Y)	-5.88%	-10.02%

Frequently asked

Which has grown faster, AUPH or BCRX?: Over the past five years, BCRX grew revenue faster — AUPH at a 40.17% CAGR versus BCRX at 64.07%.
Is AUPH or BCRX more profitable?: AUPH runs the higher net margin — AUPH at 100.84% versus BCRX at -40.90%.
How have AUPH and BCRX total returns compared?: Over the past 10 years, AUPH delivered 14.53% and BCRX delivered 5.82% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AUPH analysis Full BCRX analysis Interactive comparison tool

Dig into the metrics

Aurinia Pharmaceuticals P/E ratio Aurinia Pharmaceuticals ROE BioCryst Pharmaceuticals ROE Aurinia Pharmaceuticals operating margin BioCryst Pharmaceuticals operating margin Aurinia Pharmaceuticals revenue growth BioCryst Pharmaceuticals revenue growth Aurinia Pharmaceuticals free cash flow BioCryst Pharmaceuticals free cash flow

Aurinia Pharmaceuticals & BioCryst Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.